TR200100385T2 - Serin/treonin protein kinaz fonksiyonunun 5-azakuinoksalin-bazlı bileşikler ile modüle edilmesi için yöntemler. - Google Patents
Serin/treonin protein kinaz fonksiyonunun 5-azakuinoksalin-bazlı bileşikler ile modüle edilmesi için yöntemler.Info
- Publication number
- TR200100385T2 TR200100385T2 TR2001/00385T TR200100385T TR200100385T2 TR 200100385 T2 TR200100385 T2 TR 200100385T2 TR 2001/00385 T TR2001/00385 T TR 2001/00385T TR 200100385 T TR200100385 T TR 200100385T TR 200100385 T2 TR200100385 T2 TR 200100385T2
- Authority
- TR
- Turkey
- Prior art keywords
- methods
- serine
- threonine protein
- protein kinase
- azaquinoxaline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Mevcut bulus kismen 5-azakuinoksalin-bazli bilesikler ile serin/threonin protein kinazlarin fonksiyonunun modüle edilmesi yöntemlerine yöneliktir. Yöntemler RAF gibi bir serin/threonin protein kinazi üreten hücreleri içerir. Buna ek olarak, bulus burada tarif edilen yöntemler ile belirlenen bir bilesik ile organizmalardaki serin/treonin protein kinaz ile ilgili anormal durumlarin önlenmesi ve tedavi edilmesi yöntemlerini tarif eder. Ayrica, bulus, bulusun yöntemleri ile belirlenen bilesiklerden olusan farmasötik bilesimler ile ilgilidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6112397P | 1997-10-06 | 1997-10-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200100385T2 true TR200100385T2 (tr) | 2002-06-21 |
Family
ID=22033733
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/00906T TR200000906T2 (tr) | 1997-10-06 | 1998-10-05 | Serin/treonin protein kinaz fonksiyonunun 5-azakuinoksalin-bazlı bileşikler ile modüle edilmesi için yöntemler. |
TR2001/00385T TR200100385T2 (tr) | 1997-10-06 | 1998-10-05 | Serin/treonin protein kinaz fonksiyonunun 5-azakuinoksalin-bazlı bileşikler ile modüle edilmesi için yöntemler. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/00906T TR200000906T2 (tr) | 1997-10-06 | 1998-10-05 | Serin/treonin protein kinaz fonksiyonunun 5-azakuinoksalin-bazlı bileşikler ile modüle edilmesi için yöntemler. |
Country Status (31)
Country | Link |
---|---|
US (2) | US6180631B1 (tr) |
EP (1) | EP1028729B1 (tr) |
JP (1) | JP2001518496A (tr) |
KR (1) | KR100633270B1 (tr) |
CN (1) | CN1169527C (tr) |
AR (1) | AR013542A1 (tr) |
AT (1) | ATE336250T1 (tr) |
AU (1) | AU757585B2 (tr) |
BG (1) | BG64969B1 (tr) |
BR (1) | BR9814814A (tr) |
CA (1) | CA2306257C (tr) |
CY (1) | CY1106223T1 (tr) |
CZ (1) | CZ298775B6 (tr) |
DE (1) | DE69835612T2 (tr) |
DK (1) | DK1028729T3 (tr) |
ES (1) | ES2268791T3 (tr) |
HK (1) | HK1031836A1 (tr) |
HU (1) | HUP0100302A3 (tr) |
IL (2) | IL135103A0 (tr) |
MX (1) | MXPA03011007A (tr) |
NO (1) | NO316598B1 (tr) |
NZ (1) | NZ503431A (tr) |
PL (1) | PL192039B1 (tr) |
PT (1) | PT1028729E (tr) |
RU (1) | RU2223753C2 (tr) |
SK (1) | SK4722000A3 (tr) |
TR (2) | TR200000906T2 (tr) |
TW (1) | TWI245765B (tr) |
UA (1) | UA71555C2 (tr) |
WO (1) | WO1999017759A2 (tr) |
ZA (1) | ZA988961B (tr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA71555C2 (en) | 1997-10-06 | 2004-12-15 | Zentaris Gmbh | Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives |
JP2002534468A (ja) * | 1999-01-13 | 2002-10-15 | バイエル コーポレイション | p38キナーゼ阻害剤としてのω−カルボキシアリール置換ジフェニル尿素 |
US8124630B2 (en) * | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
AU1053501A (en) * | 1999-11-02 | 2001-05-14 | Ajinomoto Co., Inc. | Polyazanaphthalene compound and medicinal use thereof |
US7371763B2 (en) * | 2001-04-20 | 2008-05-13 | Bayer Pharmaceuticals Corporation | Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
US20080108672A1 (en) * | 2002-01-11 | 2008-05-08 | Bernd Riedl | Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors |
EP2324825A1 (en) * | 2002-02-11 | 2011-05-25 | Bayer Healthcare LLC | Aryl ureas with angiogenesis inhibiting activity |
US20040131504A1 (en) * | 2002-09-17 | 2004-07-08 | Landers James P. | Remote temperature sensing of small volume and related apparatus thereof |
US7557129B2 (en) | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
ATE366108T1 (de) * | 2003-05-20 | 2007-07-15 | Bayer Pharmaceuticals Corp | Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten |
BRPI0410633A (pt) * | 2003-05-23 | 2006-06-13 | Zentaris Gmbh | piridopirazinas e uso das mesmas como moduladores de cinase |
DE102004022383A1 (de) * | 2004-05-06 | 2005-12-01 | Zentaris Gmbh | Neue Pyridopyrazine und deren Verwendung als Modulatoren von Kinasen |
DE10323345A1 (de) | 2003-05-23 | 2004-12-16 | Zentaris Gmbh | Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren |
CA2529090A1 (en) * | 2003-06-13 | 2004-12-23 | Novartis Ag | 2-aminopyrimidine derivatives as raf kinase inhibitors |
NZ580384A (en) | 2003-07-23 | 2011-03-31 | Bayer Pharmaceuticals Corp | 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions |
EP1790342A1 (de) | 2005-11-11 | 2007-05-30 | Zentaris GmbH | Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege |
KR101400905B1 (ko) * | 2005-11-11 | 2014-05-29 | 아에테르나 젠타리스 게엠베하 | 신규한 피리도피라진 및 키나제의 조절제로서의 이의 용도 |
US8217042B2 (en) | 2005-11-11 | 2012-07-10 | Zentaris Gmbh | Pyridopyrazines and their use as modulators of kinases |
WO2010003308A1 (zh) * | 2008-07-10 | 2010-01-14 | 卞化石 | 一氧化氮及其信息传递***在制备恶性肿瘤靶向治疗药物中的应用 |
GB0812969D0 (en) | 2008-07-15 | 2008-08-20 | Sentinel Oncology Ltd | Pharmaceutical compounds |
GB201007286D0 (en) | 2010-04-30 | 2010-06-16 | Astex Therapeutics Ltd | New compounds |
GB201020179D0 (en) | 2010-11-29 | 2011-01-12 | Astex Therapeutics Ltd | New compounds |
EP2508184A1 (en) | 2011-04-06 | 2012-10-10 | Æterna Zentaris GmbH | Pyridopyrazine derivatives and their use |
GB201118675D0 (en) | 2011-10-28 | 2011-12-14 | Astex Therapeutics Ltd | New compounds |
GB201118652D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
GB201118656D0 (en) * | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
GB201118654D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
GB201209613D0 (en) | 2012-05-30 | 2012-07-11 | Astex Therapeutics Ltd | New compounds |
GB201209609D0 (en) | 2012-05-30 | 2012-07-11 | Astex Therapeutics Ltd | New compounds |
CN104903320B (zh) * | 2013-01-11 | 2018-11-13 | 富士胶片株式会社 | 含氮杂环化合物或其盐 |
GB201307577D0 (en) | 2013-04-26 | 2013-06-12 | Astex Therapeutics Ltd | New compounds |
DE102013008118A1 (de) * | 2013-05-11 | 2014-11-13 | Merck Patent Gmbh | Arylchinazoline |
JP6980385B2 (ja) | 2014-03-26 | 2021-12-15 | アステックス、セラピューティックス、リミテッドAstex Therapeutics Limited | Fgfr阻害剤とigf1r阻害剤の組合せ |
HUE053654T2 (hu) | 2014-03-26 | 2021-07-28 | Astex Therapeutics Ltd | FGFR- és CMET-inhibitorok kombinációi a rák kezelésére |
JO3512B1 (ar) | 2014-03-26 | 2020-07-05 | Astex Therapeutics Ltd | مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز |
DK3174868T3 (da) | 2014-08-01 | 2021-11-08 | Nuevolution As | Forbindelser, der er aktive mod bromodomæner |
JOP20200201A1 (ar) | 2015-02-10 | 2017-06-16 | Astex Therapeutics Ltd | تركيبات صيدلانية تشتمل على n-(3.5- ثنائي ميثوكسي فينيل)-n'-(1-ميثيل إيثيل)-n-[3-(ميثيل-1h-بيرازول-4-يل) كينوكسالين-6-يل]إيثان-1.2-ثنائي الأمين |
US10478494B2 (en) | 2015-04-03 | 2019-11-19 | Astex Therapeutics Ltd | FGFR/PD-1 combination therapy for the treatment of cancer |
KR20180052631A (ko) | 2015-09-23 | 2018-05-18 | 얀센 파마슈티카 엔.브이. | 비-헤테로아릴 치환된 1,4-벤조디아제핀 및 암의 치료를 위한 이의 용도 |
BR112018005637B1 (pt) | 2015-09-23 | 2023-11-28 | Janssen Pharmaceutica Nv | Compostos derivados de quinoxalina, quinolina e quinazolinona,composições farmacêuticas que os compreende, e uso dos referidos compostos |
US20190256492A1 (en) * | 2018-02-19 | 2019-08-22 | Washington University | Alpha-synuclein ligands |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4001017A (en) * | 1972-12-05 | 1977-01-04 | Ciba-Geigy Ag | Process for the photopolymerization of ethylenically unsaturated compounds |
US4043819A (en) * | 1974-06-11 | 1977-08-23 | Ciba-Geigy Ag | Photo-polymerizable material for the preparation of stable polymeric images and process for making them by photopolymerization in a matrix |
US5217999A (en) | 1987-12-24 | 1993-06-08 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Styryl compounds which inhibit EGF receptor protein tyrosine kinase |
DE3804990A1 (de) * | 1988-02-18 | 1989-08-31 | Basf Ag | Herbizid wirksame, heterocyclisch substituierte sulfonamide |
FR2656606B1 (fr) * | 1989-12-28 | 1993-06-25 | Roussel Uclaf | Utilisation de derives du 9,10-dihydrophenanthrene pour la preparation d'un medicament anti-tumoral, application a titre de medicaments de derives du 9,10-dihydrophenanthrene et produits derives de cette structure. |
CA2078214C (en) | 1990-04-02 | 1995-03-28 | Robert Lee Dow | Benzylphosphonic acid tyrosine kinase inhibitors |
US5302606A (en) | 1990-04-16 | 1994-04-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase |
DK0584222T3 (da) | 1991-05-10 | 1998-02-23 | Rhone Poulenc Rorer Int | Bis-mono- og bicycliske aryl- og heteroarylforbindelser, som inhiberer EGF- og/eller PDGF-receptor-tyrosinkinase |
CA2108889A1 (en) | 1991-05-29 | 1992-11-30 | Robert Lee Dow | Tricyclic polyhydroxylic tyrosine kinase inhibitors |
GB9300059D0 (en) | 1992-01-20 | 1993-03-03 | Zeneca Ltd | Quinazoline derivatives |
RU2155187C2 (ru) | 1992-08-06 | 2000-08-27 | Варнер-Ламберт Компани | Производные индола, их таутомеры, смеси их изомеров или отдельные изомеры и фармацевтически приемлемые соли, фармацевтическая композиция с антиопухолевой или ингибирующей протеин-тирозинкиназу активностью и способ торможения зависящего от протеин-тирозинкиназы заболевания или борьбы с аберрантным ростом клеток млекопитающего или человека. |
US5330992A (en) | 1992-10-23 | 1994-07-19 | Sterling Winthrop Inc. | 1-cyclopropyl-4-pyridyl-quinolinones |
GB9226855D0 (en) | 1992-12-23 | 1993-02-17 | Erba Carlo Spa | Vinylene-azaindole derivatives and process for their preparation |
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
GB9501567D0 (en) | 1995-01-26 | 1995-03-15 | Pharmacia Spa | Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
US5593997A (en) * | 1995-05-23 | 1997-01-14 | Pfizer Inc. | 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors |
US5880141A (en) | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
US5723462A (en) * | 1996-04-26 | 1998-03-03 | Neurogen Corporation | Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands |
UA71555C2 (en) | 1997-10-06 | 2004-12-15 | Zentaris Gmbh | Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives |
GB9726851D0 (en) * | 1997-12-19 | 1998-02-18 | Zeneca Ltd | Human signal transduction serine/threonine kinase |
-
1998
- 1998-05-10 UA UA2000052578A patent/UA71555C2/uk unknown
- 1998-10-01 ZA ZA9808961A patent/ZA988961B/xx unknown
- 1998-10-05 MX MXPA03011007A patent/MXPA03011007A/es not_active IP Right Cessation
- 1998-10-05 US US09/166,723 patent/US6180631B1/en not_active Expired - Fee Related
- 1998-10-05 TR TR2000/00906T patent/TR200000906T2/tr unknown
- 1998-10-05 CA CA002306257A patent/CA2306257C/en not_active Expired - Fee Related
- 1998-10-05 DK DK98948606T patent/DK1028729T3/da active
- 1998-10-05 AT AT98948606T patent/ATE336250T1/de not_active IP Right Cessation
- 1998-10-05 PL PL339860A patent/PL192039B1/pl not_active IP Right Cessation
- 1998-10-05 NZ NZ503431A patent/NZ503431A/en unknown
- 1998-10-05 WO PCT/US1998/020910 patent/WO1999017759A2/en active IP Right Grant
- 1998-10-05 CN CNB988099403A patent/CN1169527C/zh not_active Expired - Fee Related
- 1998-10-05 CZ CZ20001129A patent/CZ298775B6/cs not_active IP Right Cessation
- 1998-10-05 HU HU0100302A patent/HUP0100302A3/hu not_active Application Discontinuation
- 1998-10-05 IL IL13510398A patent/IL135103A0/xx not_active IP Right Cessation
- 1998-10-05 DE DE69835612T patent/DE69835612T2/de not_active Expired - Fee Related
- 1998-10-05 BR BR9814814-1A patent/BR9814814A/pt not_active Application Discontinuation
- 1998-10-05 ES ES98948606T patent/ES2268791T3/es not_active Expired - Lifetime
- 1998-10-05 PT PT98948606T patent/PT1028729E/pt unknown
- 1998-10-05 KR KR1020007003656A patent/KR100633270B1/ko not_active IP Right Cessation
- 1998-10-05 RU RU2000111434/15A patent/RU2223753C2/ru not_active IP Right Cessation
- 1998-10-05 SK SK472-2000A patent/SK4722000A3/sk unknown
- 1998-10-05 EP EP98948606A patent/EP1028729B1/en not_active Expired - Lifetime
- 1998-10-05 JP JP2000514630A patent/JP2001518496A/ja not_active Withdrawn
- 1998-10-05 AU AU95141/98A patent/AU757585B2/en not_active Ceased
- 1998-10-05 TR TR2001/00385T patent/TR200100385T2/tr unknown
- 1998-10-06 AR ARP980104970A patent/AR013542A1/es unknown
- 1998-10-06 TW TW087116559A patent/TWI245765B/zh not_active IP Right Cessation
-
2000
- 2000-03-15 IL IL135103A patent/IL135103A/en unknown
- 2000-04-05 NO NO20001748A patent/NO316598B1/no unknown
- 2000-04-28 BG BG104392A patent/BG64969B1/bg unknown
- 2000-10-16 US US09/688,199 patent/US6727252B1/en not_active Expired - Fee Related
-
2001
- 2001-04-10 HK HK01102529A patent/HK1031836A1/xx not_active IP Right Cessation
-
2006
- 2006-10-30 CY CY20061101554T patent/CY1106223T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200000906T2 (tr) | Serin/treonin protein kinaz fonksiyonunun 5-azakuinoksalin-bazlı bileşikler ile modüle edilmesi için yöntemler. | |
NO20001555D0 (no) | Azabenzimidazolbaserte forbindelser for modulering av serin/treonin proteinkinasefunksjon | |
ATE441418T1 (de) | Verwendung von treprostinil zur verbesserung der nierenfunktion | |
ATE457970T1 (de) | Zusammensetzungen zur beseitigung von unangenehmen gerüchen | |
CO5640039A2 (es) | Compuesto de pirazol-amida sustituidos utiles como inhibidores de cinasa | |
HN1998000143A (es) | Tetrahidronaftalenos substituidos y compuestos analogos. | |
BR0207278A (pt) | Derivados de ftalazinona-piperidina como inibidores de pde4 | |
CA2122338A1 (en) | Novel human cdc25 genes, encoded products and uses therefor | |
EA200100139A1 (ru) | Фармацевтические композиции, содержащие 2-хинолоны | |
TR199900843A2 (tr) | Sübstitüe edilmis trisiklik bilesikler. | |
ATE26835T1 (de) | Tris(piperidylaminotriazylamino) verbindungen, ihre herstellung und ihre verwendung als stabilisierungsmittel fuer polymere. | |
ATE220679T1 (de) | Porphyrine und ihre verwendung als photosensitizer | |
BR0016547A (pt) | Composição para a modulação e inibição da permeabilidade vascular (vp) | |
ES2153748A1 (es) | Mezcla sinergica de estabilizadores a base de compuestos de polialquil-1-1-oxa-diaza-espirodecano. | |
DE50000504D1 (de) | Ionische flüssigkeiten, ihre herstellung und ihre verwendung | |
DE60306371D1 (en) | Amorphe feste modifikation von bis(2,4-dicumylphenyl) pentaerythritdiphosphit | |
TR199901274T2 (tr) | Farnezil protein transferaz inhibitörleri olarak yararli yeni trisiklik piperidinil bilesikleri | |
AU1792697A (en) | Photosensitive composition | |
DE3879478T2 (de) | Ornithin-derivate und deren verwendung als inhibitoren von methothrexat resistenten zellen. | |
DE50003001D1 (de) | Verwendung von porphyrinderivaten in aquarien | |
DE60108089D1 (de) | Heterozyclische oder benzol derivate von liponsäure, deren herstellung und deren verwendung als heilmittel | |
DE502004009016D1 (de) | Verwendung von chinaldin-und naphthalinderivaten als kristallisationsmodifikatoren | |
AR035411A1 (es) | Uso de un derivado de tacrolimus para fabricar un agente neurotrofico, composiciones y articulos de fabricacion o kits que lo comprenden, metodo para fabricar un agente que lo comprende y tejidos e injertos con una celula nerviosa tratada con este compuesto | |
PA8478901A1 (es) | Isoquinolinas | |
DE59901563D1 (de) | N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung |